CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.040
-0.010 (-0.33%)
At close: May 27, 2026, 4:00 PM EDT
3.239
+0.199 (6.53%)
After-hours: May 27, 2026, 6:51 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $28.15 million as of May 27, 2026. Its market cap has decreased by -61.91% in one year.
Market Cap
28.15M
Enterprise Value
15.41M
1-Year Change
-61.91%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $28.15M, a decrease of -34.94%. That is a compound annual growth rate of -14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 28.24M | -61.37% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 29.13M |
| NeuroSense Therapeutics | 28.99M |
| ABVC BioPharma | 28.81M |
| Polyrizon | 28.56M |
| IGC Pharma | 28.45M |
| Lisata Therapeutics | 28.36M |
| Kyntra Bio | 28.30M |
| NextCure | 28.25M |